CAREMAX INC (CMAX)
US14171W2026 - Common Stock
ChartMill assigns a Buy % Consensus number of 46% to CMAX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 43.25. This target is 10160.5% above the current price.
CMAX was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about CMAX.
In the previous month the buy percentage consensus was at a similar level.
CMAX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-01 | UBS | Maintains | Neutral -> Neutral |
| 2023-11-17 | UBS | Downgrade | Buy -> Neutral |
| 2023-11-10 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2023-01-06 | UBS | Maintains | Buy |
| 2022-09-07 | Truist Securities | Initiate | Hold |
| 2021-10-20 | Jefferies | Initiate | Buy |
| 2021-09-13 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2021-09-10 | Cowen & Co. | Initiate | Outperform |
| 2021-07-01 | Piper Sandler | Initiate | Neutral |